再鼎医药（09688）今日盘中大涨5.12%，引起市场广泛关注。这一显著涨幅可能与近期南向资金的持续增持有关。
根据最新数据显示，7月21日，南向资金增持再鼎医药359.46万股，这已经是连续第四个交易日增持该股。截至7月21日收盘，港股通共持有再鼎医药26669.23万股，占流通股的24.01%。这表明机构投资者对再鼎医药的未来发展持积极态度，可能是推动股价上涨的重要因素之一。
值得注意的是，再鼎医药在过去5个交易日已上涨2.43%，港股通累计增持858.20万股。而在过去20个交易日中，尽管股价下跌1.26%，港股通仍累计增持4265.78万股。这种持续的增持行为可能反映了机构投资者对公司长期价值的看好，进而引发了今日的大幅上涨。投资者应密切关注公司未来的业务发展和市场表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.